Learn More
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 100 MG

Supplier: Medchemexpress LLC HYN1584A100MG
Halofuginone hydrobromide (RU-19110 hydrobromide) is a competitive prolyl-tRNA synthetase inhibitor. This Febrifugine derivative acts as a specific inhibitor of type-I collagen synthesis and helps in attenuating osteoarthritis by inhibiting TGF-β activity. It also functions as a potent pulmonary vasodilator through the activation of Kv channels and blocking voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Acts as a competitive prolyl-tRNA synthetase inhibitor.
- Inhibits type-I collagen synthesis.
- Attenuates osteoarthritis by inhibiting TGF-β activity.
- Functions as a potent pulmonary vasodilator.
- Activates Kv channels.
- Blocks voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Possesses anti-malaria effects.
- Demonstrates anti-inflammatory properties.
- Exhibits anti-cancer and anti-fibrosis effects.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.